Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-25

Clinical Trial Update: Serum Endocan, Alarin, and Galanin-Like Peptide Levels in Diabetic Retinopathy [NA]

View source ↗

Summary

This completed clinical trial investigated serum levels of endocan, alarin, and galanin-like peptide in individuals with diabetic retinopathy and diabetes melli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elazıg Fethi Sekin Sehir Hastanesi | Conditions: Diabetic Retinopathy, Diabetes Mellitus | NA | Status: COMPLETED